- EyePoint Pharmaceuticals ( NASDAQ: EYPT ) promotes company's COO since November 2021, Jay S. Duker, M.D., to the additional role of President.
- In addition to continuing to oversee his duties as COO, in his expanded role, Dr. Duker will also oversee regulatory affairs.
- Prior to serving as COO at the company, Dr. Duker held earlier roles as Chief Strategic Scientific Officer on a part-time basis beginning in 2020, after having served as an independent member of the company’s Board of Directors since 2016.
For further details see:
EyePoint Pharmaceuticals promotes Jay S. Duker to President